Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “AEROSOLS”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 415 records · Page 23Linked to original sources

Contribution of first- versus second-generation products to secondary organic aerosols formed in the oxidation of biogenic hydrocarbons.

Biogenic hydrocarbons emitted by vegetation are important contributors to secondary organic aerosol (SOA), but the aerosol formation mechanisms are incompletely understood. In this study, the formation of aerosols and gas-phase products from the ozonolysis and photooxidation of a series of biogenic hydrocarbons (isoprene, 8 monoterpenes, 4 sesquiterpenes, and 3 oxygenated terpenes) are examined. By comparing aerosol growth (measured by Differential Mobility Analyzers, DMAs) and gas-phase concentrations (monitored by a Proton Transfer Reaction Mass Spectrometer, PTR-MS), we study the general mechanisms of SOA formation. Aerosol growth data are presented in terms of a "growth curve", a plot of aerosol mass formed versus the amount of hydrocarbon reacted. From the shapes of the growth curves, it is found that all the hydrocarbons studied can be classified into two groups based entirely on the number of double bonds of the hydrocarbon, regardless of the reaction systems (ozonolysis or photooxidation) and the types of hydrocarbons studied: compounds with only one double bond and compounds with more than one double bond. For compounds with only one double bond, the first oxidation step is rate-limiting, and aerosols are formed mainly from low volatility first-generation oxidation products; whereas for compounds with more than one double bond, the second oxidation step may also be rate-limiting and second-generation products contribute substantially to SOA growth. This behavior is characterized by a vertical section in the growth curve, in which continued aerosol growth is observed even after all the parent hydrocarbon is consumed.

Aerosols↗

Spray dried powders and powder blends of recombinant human deoxyribonuclease (rhDNase) for aerosol delivery.

PURPOSE: We have used rhDNase to investigate the feasibility of developing a dry protein powder aerosol for inhalation delivery. METHODS: Powders of rhDNase alone and with sodium chloride were prepared by spray drying. Powder blends were obtained by mixing (tumbling and sieving) pure rhDNase powder with 'carrier' materials (lactose, mannitol or sodium chloride). The weight percent of drug in the blends was between 5 and 70%. The particle size distributions and crystallinity of the spray dried powders were obtained by laser diffraction and X-ray powder diffraction, respectively. Particle morphology was examined by scanning electron microscopy. The ability of the powders and powder blends to be dispersed into respirable aerosols was measured using a Rotahaler connected to a multistage liquid impinger operating at 60 L/min. RESULTS: Pure rhDNase powder was quite cohesive with a fine particle fraction (FPF or "respirable fraction': % wt. of particles < 7 microns in the aerosol cloud) of about 20%. When particles also contained NaCl, the powders were dispersed better to form aerosols. A linear relationship was observed between the NaCl content and FPF for a similar primary size (approximately 3 microns volume median diameter) of particles. The particle morphology of these powders varied systematically with the salt content. For the blends, SEM revealed a monolayer-like adhesion of the fine drug particles to the carriers at drug contents > or = 50% wt. An overall 2-fold increase in FPF of rhDNase in the aerosol cloud was obtained for all the blends compared to the pure drug aerosols. CONCLUSIONS: The aerosol properties of spray dried rhDNase powders can be controlled by incorporation of a suitable excipient, such as NaCl, and its relative proportion. Coarse carriers can also enhance the performance of rhDNase dry powder aerosols.

Aerosols↗

Aerosolized surfactant and dextran for experimental acute respiratory distress syndrome caused by acidified milk in rats.

BACKGROUND: Inhibition of pulmonary surfactant by plasma-derived proteins is an important pathogenetic factor of acute respiratory distress syndrome (ARDS). Inhalation of aerosolized surfactant may be suitable for early treatment of ARDS. However, requirement of a high dose is a drawback. Because dextran reverses surfactant inhibition, we examined whether dextran improves the therapeutic effects of aerosolized surfactant in rats with experimental ARDS. METHODS: Acidified milk (pH 1.8, 1.5 ml kg(-1)) was injected into the trachea of the rats ventilated with pure oxygen using 2.45 kPa peak inspiratory pressure and 0.74 kPa positive end-expiratory pressure. When PaO2 decreased to <13 kPa, the rats were assigned to four groups: control group (n = 8), receiving no material; D-only group (n = 6), receiving aerosolized dextran for 45 min; S-only group (n = 8), receiving aerosolized modified natural surfactant (MNS) for 30 min; and S-plus-D group (n = 9), receiving aerosolized MNS for 30 min followed by aerosolized dextran for 15 min. RESULTS: In the control group and D-only groups, the mean PaO2 remained at <10 kPa for 180 min. In the S-only and S-plus-D groups, the PaO2 increased to 50 kPa (P < 0.01 vs. untreated). The PaO2 of the surfactant-only group gradually decreased to <17 kPa at 180 min, whereas the PaO2 of the S-plus-D group was maintained at >38 kPa for 180 min (P < 0.01 vs. S-only group). CONCLUSION: Inhalation of aerosolized dextran potentiates the effects of aerosolized surfactant by prolonging the therapeutic response.

Aerosols↗

Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin.

Growth inhibition of established tumor metastases in the lungs poses a difficult challenge for most clinical settings in spite of extensive multi-modality approaches. Aerosol delivery of drugs and genes holds promise for the treatment of disseminated lung metastases, since aerosol delivery can target the lungs specifically and uniformly. We previously demonstrated that aerosol delivery of dilauroylphosphatidylcholine liposome formulation of 9-nitrocamptothecin (9NC-DLPC) inhibits B16-F10 melanoma lung metastases. Aerosol delivery of polyethleneimine-p53 DNA (PEI-p53) complexes results in a similar anti-tumor effect in the B16-F10 model. In both these previous studies, the protocols were designed to inhibit development of lung metastases. In this study we demonstrate, using the B16-F10 melanoma lung metastasis model, that sequential aerosol delivery of PEI-p53 and 9NC-DLPC acts additively to inhibit growth of established B16-F10 tumor metastases in the lungs. Mice injected with B16-F10 cells and treated with a combination of 9NC-DLPC (twice weekly) and PEI-p53 (once weekly) aerosol complexes starting on day 11 after tumor inoculation, exhibited a highly significant (P < 0.01) reduction in the number of visible tumor foci as compared with untreated mice or mice treated with either single agent alone, or with a combination of 9NC and a control plasmid. There was a highly significant reduction in the tumor burden, as well as the lung weights for the 9NC and p53 combination group (P < 0.001 as compared with other groups). Moreover, the doses of p53 gene and 9NC in the combination group were reduced at least two-fold as compared with our previous single agent studies, but still achieved significant tumor inhibition. Furthermore, the sequential aerosol delivery of p53 and 9NC lead to a 30-40% increase in the mean survival time of these mice, as compared with animals in different control groups. The data suggest that the combination of 9NC and p53 gene delivered by aerosol is an attractive strategy for growth inhibition of established tumor metastases in the lungs.

Aerosols↗

Possibility of blood and hepatitis B contamination through aerosols generated during debonding procedures.

The primary purpose of this study was to investigate the presence of blood or blood elements in aerosols generated during the debonding procedures. The presence of three hepatitis B carriers in the study group led us to investigate the possibility of hepatitis B virus (HBV) contamination through aerosols, which was the secondary purpose of the study. The study group consisted of 26 patients who had a mean age of 16 +/- 2 years. Collection of aerosol samples was done using a saliva ejector that fit on the handle of the high-speed dental instrument and was attached to a mobile evacuator. A second evacuator was used to remove and collect excess fluid accumulated in the patient's mouth. The guaiac method was used to investigate the presence of occult blood in aerosol and in excess fluid samples. Serum, excess fluid, and aerosol samples of three hepatitis B carriers were tested by enzyme-linked immunosorbent assay for detecting hepatitis B surface antigen (HBsAg) and by polymerase chain reaction for detecting HBV-deoxyribonucleic acid (DNA). Blood was found in all the aerosols and in excess fluid samples. HBsAg was detected in excess fluid samples of the two hepatitis B carriers, whereas HBV-DNA was detected in only one of the excess fluid samples. HBsAg and HBV-DNA were detected in aerosol sample of only one hepatitis B carrier. The results of this study showed that aerosols generated during the debonding procedure should always be considered as potential hazards to health.

Adolescent↗

Copper oxide aerosol: generation and characterization.

Effluent gases from high temperature systems such as fossil fuel combustion and pyrometallurgical processes contain inorganic material which has the potential to interact with sulfur dioxide (SO2) on the surface of particles to form an irritant aerosol. The submicron fraction of this inorganic material is especially important as the fine particles may penetrate deep into the lung and cause serious health effects. A laboratory furnace was designed to produce a submicrometer copper oxide aerosol to stimulate emissions from copper smelters and other pyrometallurgical operations. The ultimate aim of this research is to investigate the interaction of SO2 and the copper oxide aerosol at different temperatures and humidities in order to determine the reaction products and their potential health effects upon inhalation. The initial work, as presented in this paper, was to reproducibly generate a submicrometer copper oxide aerosol and to characterize it in terms of size, morphology and composition. Two experimental regimes were set up. One admitted filtered air, without water vapor, into the furnace, and the other admitted filtered air and water vapor. The size and morphology of the aerosols were determined using an electrical aerosol analyzer and transmission electron microscopy. The particles appear as chain aggregates with a count median diameter of 0.026 micron when no water vapor was added and 0.031 micron when water vapor was added into the furnace. Composition of the aerosol was determined using x-ray photoelectron spectroscopy. The aerosol, with or without water in the furnace, consists of a mixture of copper(I) oxide and copper(II) hydroxide.

Aerosols↗

Aerosol penetration through filtering facepieces and respirator cartridges.

Air-purifying respirators must be certified following the National Institute for Occupational Safety and Health (NIOSH) filter test criteria (30 CFR 11). The criteria specify a range for the mean particle size and the measure of spread permissible for the test aerosol. The authors' experiments have shown that aerosol penetration as a function of particle size differs considerably among certified respirators of the same type. Filtering facepieces (disposable respirators) and cartridges of the dust-mist, dust-mist-fume, and high-efficiency particulate air type were tested. The respirators were sealed to mannequins in a test chamber. The aerosol concentrations inside and outside the respirator were measured by an aerodynamic particle sizer and a laser aerosol spectrometer over a particle size range of 0.1 to 15 microns. Five flow rates ranging from 5 to 100 L/min were used to study flow dependency. The aerosol penetration through the filters is presented as a function of particle size. Aerosol penetration and pressure drop are combined to express the performance of each filter in terms of "quality factor." Under the same test conditions, the quality factor of one respirator may be as much as 6.6 times more than that of another respirator of the same type. The filter quality factor has a greater aerosol size dependency as airflow and aerosol size increase. In general, cartridges have a larger surface area than filtering facepieces but not necessarily lower filter penetration or higher filter quality.(ABSTRACT TRUNCATED AT 250 WORDS)

Aerosols↗

Comparison of simulated respirator fit factors using aerosol and vapor challenges.

Although not well established, mask leakage measured using submicron aerosol challenges is generally accepted as being representative of vapor challenges. The purpose of this study was to compare simulated respirator fit factors (FFs) measured using vapor challenges to those measured using an aerosol challenge. A full-facepiece respirator was mounted on a headform inside a small enclosure and modified with controlled leaks (laser-drilled orifices) to produce FFs ranging from about 300 to 30,000. A breathing machine was used to simulate breathing conditions of 1.0 L tidal volume and 25 breaths/min. A monodisperse aerosol consisting of 0.72 micron polystyrene latex spheres (PSL) was used for the reference test aerosol, and FFs were measured using a laser aerosol spectrometer. An inert gas, sulfur hexafluoride (SF6), and an organic vapor, isoamyl acetate (IAA), were used as the vapor challenges. The in-mask concentration of SF6 was measured using a gas chromatograph (GC). A GC was also used to quantify in-mask IAA concentration samples actively collected with sorbent tubes. FF measurements made with the PSL aerosol challenge were conducted in sequence with the SF6 and IAA challenges, without disturbing the mask, to yield matched data pairs for regression analysis. FFs measured using the PSL reference aerosol were found to correlate well with those measured with the SF6 (r2 = 0.99) and IAA (r2 = 0.98) vapor challenges. FFs measured using IAA tended to be higher at values below 10,000. The best agreement was observed with the inert gas, SF6. The results of this study suggest that submicron aerosols are suitable as quantitative fit test challenges for assessing the performance of respirators against inert vapors.

Aerosols↗

Powered, air-purifying particulate respirator filter penetration by a DOP aerosol.

In 1995, new certification requirements for all nonpowered, air-purifying particulate filter respirators were put in place when 42 CFR 84 replaced 30 CFR 11. However, the certification requirements for all other classes of respirators, including powered air-purifying respirators (PAPRs), were transferred to 42 CFR 84 from 30 CFR 11 without major changes. Since the inception of 42 CFR 84, researchers have learned that the efficiency of electrostatic filter media, in contrast with mechanical filter media, can be rapidly degraded by oil aerosols. Further, confusion may exist among respirator users, since electrostatic PAPR filters have the same magenta color assigned to high-efficiency filters for nonpowered particulate respirators that have been tested and certified for use against oil aerosols (i.e., P100 filters). Users may expect that the magenta color of certified PAPR filters indicates suitability for use against oil aerosols. This may not be the case. To illustrate the potential degradation of electrostatic PAPR filters, new filters certified under 42 CFR 84 were tested using a TSI model 8122 Automated Respirator Tester against charged and neutralized DOP aerosols with intermittent loading schedules. The performance of a magenta-colored electrostatic PAPR filter--one for which the manufacturer's user instructions appropriately indicates is not suitable for use in oily environments--was compared with the performance of several mechanical PAPR filters. In tests against both DOP aerosols, the electrostatic PAPR filter showed a significant decrease in performance at DOP loadings exceeding 400 mg, whereas mechanical filters showed no significant change in the performance except at extremely high loadings. The decreased performance of the electrostatic PAPR filter was found to be significantly greater when tested against a neutralized DOP aerosol when compared with a charged DOP aerosol. While laboratory tests show that the filtration efficiency of this electrostatic PAPR filter degrades with exposure to DOP aerosol, the observed laboratory degradation may or may not affect workplace performance, as similar degradation has not been verified in workplace studies. Based on these laboratory results, a proposed method for evaluating high-efficiency PAPR filters is presented. This proposed method would ensure that high-efficiency PAPR filters (> or = 99.97% efficient and magenta in color) meet critical performance criteria when loaded.

Aerosols↗

Effect of relative humidity on mixed aerosols in atmosphere.

In this study, the effects of relative humidity on the deliquescent point and size of internally mixed aerosols diameter, NH4NO3 and (NH4)2SO4 were investigated using a Tandem Differential Mobility Analyzer (TDMA) with a relative humidity conditioner. The growth of mixed aerosols appears to have two deliquescent steps. The first one was at about 61.2-61.3%, but the second one was at around 77-78%. At the first deliquescence point, growth ratio at phase change was 7.5%, which agrees with the growth ratio of ammonium nitrate aerosol. Growth ratio of phase change at the second deliquescence point was about 20%, lower than the growth ratio of ammonium sulfate aerosol. In the relative humidity range of 80-85%, the growth ratio of the mixed aerosols reached 60%. In other words, it appears that growth ratio increases with the size of aerosol. Furthermore, a theoretical growth model of mixed aerosols was developed and applied to estimate the amount of composition of the mixed aerosols dissolved at each deliquescence point. The results also show that some of ammonium sulfate already dissolved at the first deliquescence point according to the theoretical growth model.

Aerosols↗

Quantitative evaluation of aerosol deposition pattern in the lung in patients with chronic bronchitis.

A number of numeric measurements have been suggested to describe the pattern of deposition of inhaled aerosols, but there is little information about the relationship between the different measurements. We compared four different methods for analysis of aerosol deposition pattern with respect to their ability to separate patients with chronic bronchitis (CB) from healthy subjects, and with respect to their relationship to a simple index of airflow obstruction. Twelve healthy subjects and 22 patients with CB were studied. All the subjects inhaled a radiolabelled aerosol produced with an air-jet nebulizer. The aerosol contained albumin millimicrospheres labelled with 99Tcm. The ratio of peripheral to central deposition--the penetration index, the coefficient of variation, the coefficient of skewness and the quotient between maximum and mean value deposition were calculated using a gamma camera. The differences between the patients and the healthy subjects were statistically significant for all variables (p < 0.001). The sensitivity of measurements of aerosol deposition for detection of CB was similar to that of forced expiratory volume in one second (FEV1). We found strong correlations between the indices of aerosol deposition and FEV1 between all indices. In clinical routine practice, studies of aerosol deposition offer little advantage in the evaluation of patients with CB. Any of the indices may be suitable for evaluation of aerosol deposition in e.g. studies of inhaled pharmaceuticals.

Administration, Inhalation↗

In vitro aerosol performance and dose uniformity between the Foradile Aerolizer and the Oxis Turbuhaler.

Dry powder inhalers for eformoterol fumarate dihydrate, a long-acting beta-2 agonist for bronchodilation, are currently available as the Foradile Aerolizer and the Oxis Turbuhaler. The two products are different in the formulation, the aerosol production mechanism, and the device resistance to air flow. These disparities are likely to lead to different aerosol characteristics. Our objective was to compare the in vitro performance of these two inhalers in producing eformoterol aerosols. Emitted dose uniformity was measured using a sampling apparatus described in the British Pharmacopaeia. Ten individual doses (dose number 2, 3, 15, 16, 30, 31, 45, 46, 59, and 60) of the entire content (60 doses) were collected from the Aerolizer and the Turbuhaler (six inhalers each). Particle size distribution of the aerosols generated by the two inhalers were measured by a multiple stage liquid impinger at four different air flows (30-120 L/min). Eformoterol collected from the sampling devices was measured by HPLC. Fine particles are those of < or = 1.7-5.0 microm in size in the aerosols obtained by interpolation of the data at the specified air flow. The Aerolizer showed a slight dependence of the emitted dose on the air flow, with the average emitted dose increased from 80% (at 30 L/min) to 90% (at higher flows) of the 12-microg label claim as compared with 60% for the Turbuhaler. When the emitted dose was normalized by the average emitted dose value, the Aerolizer showed less variation in the normalized emitted dose uniformity than the Turbuhaler. At high air flows, 90 and 120 L/min, both inhalers produced similar amounts (4 microg) of fine particles in the aerosol per dose discharged. As the flow as decreased to 30 and 60 L/min, both inhalers produced significantly less fine particles (p < 0.05), with the Oxis Turbuhaler producing lesser amounts than the Foradile Aerolizer. However, due to the different device resistance, comparing the inhaler performance at the same inspiratory effort may be more appropriate. At a comfortable effort of 40 cm H2O, the Foradile Aerolizer would produce a significantly higher fine particle mass in the aerosols. We conclude that the two inhalers were dissimilar in the emitted dose uniformity. The fine particle mass of eformoterol produced by the two inhalers was equivalent at high but not at low air flows. The disparities may be due to the difference in the formulation and the aerosol generation mechanism of the inhalers.

Aerosols↗

Targeting delivery of aerosols to different lung regions.

With the increasing use of aerosolized drugs, there is a need to understand the means by which these drugs can most effectively be targeted to desired regions of the lung. Several attempts have been made at targeting aerosols in the lung by changing particle sizes and breathing patterns with varying degrees of success. Recent use of such techniques as shallow, aerosol bolus delivery and extremely slow inhalations of aerosols in diagnostic lung tests may also prove beneficial for targeting drug delivery to the conducting airways. This review discusses the potential for utilizing aerosol delivery techniques for selectively targeting aerosol deposition along both serial and parallel pathways in the lung. Based on a review of previous studies concerning factors that determine aerosol and gas distribution in the lung, the potential for utilizing various breathing techniques in concert with variations in particle sizes are considered. Further research on the factors that determine distribution of aerosol in the diseased lung may help in designing successful targeting strategies for the future.

Administration, Inhalation↗

Aerosol number concentrations and size distributions at mountain-rural, urban-influenced rural, and urban-background sites in Germany.

Long-term aerosol measurements have been made at three sites in Germany, representing different levels of pollution: Hohenpeissenberg (mountain-rural), Melpitz (urban-influenced rural), and Leipzig (urban background). (Urban background aerosol represents a mixture of aerosols emitted in the city and aerosols transported into the city measured at a site with no direct emissions nearby.) To provide data that will allow better estimates of the influence of environmental aerosol particles on humans, we review diurnal variations of mean total number concentrations and size distributions of submicrometer environmental aerosol particles (including ultrafine particles smaller than 100 nm) for winter and summer periods in these three regions. Number concentrations and size distributions are compared and related to peak traffic periods and to meteorologically induced new-particle formation processes. The number concentration increase with increasing level of pollution. The mountain-rural site shows the smallest and the urban background site the highest number concentration. The relative diurnal variation of the number concentration between day and night, however, is for all sites nearly the same. Generally, traffic-related number concentration during rush-hour periods peaks in the size range of 20-30 nm. Due to weaker atmospheric convective processes in winter, this traffic-related aerosol is more pronounced than that in summer. In summer, meteorologically induced new-particle formation processes add another number concentration peak to the aerosol near 10 nm. This peak occurs near noon, independent of the day of the week. For the mean number concentrations and size distribution, this new-particle formation process was only relevant for the urban-influenced rural and the urban-background sites.

Aerosols↗

Aerosol delivery of a beta-galactosidase adenoviral vector to the lungs of rodents.

Aerosol delivery of adenoviral vectors is of particular interest in regard to gene therapy for cystic fibrosis (CF), with potential advantages of more uniform respiratory delivery, a less invasive approach, and ease of repetition. The AdHCMVsp1LacZ (AdLacZ) adenoviral vector was used to evaluate the feasibility of aerosol delivery to the respiratory epithelium in rodents. The adenoviral vector tolerated aerosol generation as measured by recovery in an all-glass impinger. Using an Andersen sampler to mimic the human respiratory tract, aerosol particles were found to have an average mass mean aerodynamic diameter of 1.6 microns and a geometric standard deviation of 1.7 microns. Cotton rats and mice exposed to viral aerosols demonstrated beta-galactosidase expression in up to 10-30% of the epithelial surface of the small and large airways, whereas expression in Sprague Dawley rats was largely limited to the alveolar epithelium. Transgene expression was distributed uniformly through both lungs in animals treated by aerosol. The variables for aerosol delivery are complex and include viral titer, aerosol device, duration of exposure, species of recipient, and respiratory behavior among other factors. Species differences in expression in airways as compared to alveolar epithelium have important implications for clinical application.

Adenoviridae↗

Selective deposition of inhaled aerosols to mechanically ventilated rabbits.

We have studied selective deposition of tracer aerosols to specific sites in airways and peripheral regions of the rabbit lung by varying droplet size and breathing pattern. The different breathing patterns were controlled by a Servo Ventilator 900C and different droplet sizes (polydisperse) were generated by an air jet nebulizer (MA2) using two types of impactor vessels (MMD 2.3 and 4.1 microns). Three tracer aerosols were evaluated; Evans blue dye, 99mTc-DTPA and monodisperse fluorescent polylatex spheres (PLS). When we combined large droplets with "rapid-shallow" breathing (central deposition mode, CDM), 30% of the aerosol was deposited in the central airways. When small droplets were combined with "deep-slow" breathing (peripheral deposition mode, PDM) 60% was deposited in the peripheral part of the lung. The different detection techniques showed similar results but gave complementary information. Since detection of the radiolabelled aerosol was more sensitive than the other methods, less aerosol could be given allowing a more precise evaluation of the deposition, both from the macro autoradiographic images as well as from the well counter measurements. In order to investigate how far into the lung periphery the aerosol could be detected, we used PSL microspheres. PLS could be detected in the alveolar region by a fluorescent light microscope. However, a complete selectivity can not be obtained by aerosol delivery. The different technique used to reach selective deposition, showed that it is only possible to deposit the aerosol either more to the central or more to the peripheral parts of the respiratory tract in small subjects.

Administration, Inhalation↗

Rationale for the choice of an aerosol delivery system.

The choice of an aerosol delivery system depends on numerous factors such as the drug itself, the characteristics of the aerosol generator, the patient and his or her disease, the physician, and the clinical setting, notably an emergency situation or not. Some rules always apply: an ultrasonic nebulizer should not be used to aerosolize a drug suspension; whenever possible, the same type of aerosol generator should be used for all inhaled medications received by a given patient; for outpatients, education is a major factor to ensure treatment efficacy. When the deposition of the aerosolized drug is aimed at the terminal respiratory units, nebulizers that generate micronic aerosols should be chosen. When the deposition of the aerosolized drug is aimed at the conducting airways, the metered dose inhaler (MDI) is the first choice. However, the MDI is often ill-used, notably in children and elderly people. Therefore, other inhalation devices have been developed: spacers, dry-powder inhalers, breath-actuated MDIs and, more recently, piezo-electric devices. They have been shown to increase lung deposition of drugs in poor coordinators but they all have limitations, which may affect their clinical efficacy. These limitations include the cumbersome dimensions of spacers, the dependency of lung deposition of dry powders on the inspiratory flow rate, the need for reformulation of breath-actuated or not MDIs with CFC-free gases. Nebulization of drugs should be considered only when no portable device is available for the considered drug, or in case of failure of other forms of aerosol administration.

Aerosols↗

Influence of room geometry and ventilation rate on airflow and aerosol dispersion: implications for worker protection.

Knowledge of dispersion rates and patterns of radioactive aerosols and gases through workrooms is critical for understanding human exposure and for developing strategies for worker protection. The dispersion within rooms can be influenced by complex interactions between numerous variables, but especially ventilation design and room furnishings. For this study, dependence of airflow and aerosol dispersion on workroom geometry (furnishings) and ventilation rate were studied in an experimental room that was designed to approximate a plutonium laboratory. Three different configurations of simulated gloveboxes and two ventilation rates (approximately 6 and 12 air exchanges per hour) were studied. A sonic anemometer was used to measure airflow parameters including all three components of air velocity vectors and turbulence intensity distributions at multiple locations and heights. Aerosol dispersion rates and patterns were measured by releasing aerosols multiple times from six different locations. Aerosol particle concentrations resolved in time and space were measured using 16 multiplexed laser particle counters. Comparisons were made of air velocities, turbulence, and aerosol transport across different ventilation rates and room configurations. A strong influence of ventilation rate on aerosol dispersion rates and air velocity was found, and changes in room geometry had significant effects on aerosol dispersion rates and patterns. These results are important with regards to constant evaluation of placement of air sampling equipment, benchmarking numerical models of room airflow, and design of ventilation and room layouts with consideration of worker safety.

Aerosols↗